Abstract
Our aim was to characterise the germline BRCA1 mutation profile in Latvian breast cancer and ovarian cancer patients, to develop an effective BRCA1 gene mutation detection strategy, and to document genotype–phenotype correlations in mutation carriers. The entire BRCA1 gene was analysed in 75 breast cancer and 30 ovarian cancer patients. Screening for three mutations (5382insC, 4154delA and 300T>G) was carried out in 55 breast cancer and 66 ovarian cancer patients, and for two mutations, 5382insC and 4154delA, in 376 unselected patients with any cancer (including 51 breast cancer and 29 ovarian cancers) and 215 women with any gynaecological tumour. Mutation detection techniques used were SSCP/HD analysis or F-SSCP (ABI PRISM 310). Five different deleterious mutations were detected by analysis of the entire BRCA1 gene. The proportion of cases with mutations amongst 50 breast cancer patients diagnosed before 48 years was 26.0% (95% CI: 14.6–40.3%). Two mutations (5382insC and 4154delA) made up more than 80% of all mutations identified by the analysis of the entire BRCA1 gene in Latvia, at present. Further screening for only the prevalent mutations in different cancer patient groups resulted in the identification of 53 more mutation carriers. We conclude that breast cancer diagnosed before the age of 48 years and ovarian cancer before 65 years are criteria for DNA testing to be offered to women in Latvia, regardless of cancer history in the family. The observed associations of specific prevalent mutations with cancer site and age at onset of disease are discussed.
Similar content being viewed by others
References
SA Narod J. Boyd (2002) ArticleTitleCurrent understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer Curr Opin Obstet Gynecol 14 19–26 Occurrence Handle10.1097/00001703-200202000-00004 Occurrence Handle11801872
ME. Robson (2002) ArticleTitleClinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer Cancer Control 9 457–465 Occurrence Handle12514563
A Liede SA. Narod (2002) ArticleTitleHereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2 Hum Mutat 20 413–424 Occurrence Handle1:CAS:528:DC%2BD38Xps1yjs7w%3D Occurrence Handle12442265
JL. Hopper (2001) ArticleTitleGenetic epidemiology of female breast cancer Semin Cancer Biol 11 367–374 Occurrence Handle10.1006/scbi.2001.0392 Occurrence Handle1:CAS:528:DC%2BD3MXmvVGgtrk%3D Occurrence Handle11562179
B Csokay L Tihomirova A Stengrevics et al. (1999) ArticleTitleStrong founder effects in BRCA1 mutation carrier breast cancer patients from Latvia: mutation in brief no. 258. Online Hum Mutat 14 92 Occurrence Handle10.1002/(SICI)1098-1004(1999)14:1<92::AID-HUMU23>3.0.CO;2-2 Occurrence Handle1:STN:280:DyaK1MznsV2guw%3D%3D
B Gorski T Byrski T Huzarski et al. (2000) ArticleTitleFounder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer Am J Hum Genet 66 1963–1968 Occurrence Handle10.1086/302922 Occurrence Handle1:CAS:528:DC%2BD3cXntV2ju7w%3D Occurrence Handle10788334
O Oszurek B Gorski J Gronwald et al. (2001) ArticleTitleFounder mutations in the BRCA1 gene in west Belarusian breast-ovarian cancer families Clin Genet 60 470–471 Occurrence Handle10.1034/j.1399-0004.2001.600611.x Occurrence Handle1:STN:280:DC%2BD387htlagtA%3D%3D Occurrence Handle11846741
DH Tobias C Eng LD McCurdy et al. (2000) ArticleTitleFounder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients Gynecol Oncol 78 148–151 Occurrence Handle10.1006/gyno.2000.5848 Occurrence Handle1:CAS:528:DC%2BD3cXltlCjtbw%3D Occurrence Handle10926794
J Menkiszak J Gronwald B Gorski et al. (2003) ArticleTitleHereditary ovarian cancer in Poland Int J Cancer 106 942–945
SV Hodgson E Heap J Cameron et al. (1999) ArticleTitleRisk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer J Med Genet 36 369–373 Occurrence Handle1:CAS:528:DyaK1MXjslKlsr8%3D Occurrence Handle10353781
S Sanjose M Leone V Berez et al. (2003) ArticleTitlePrevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study Int J Cancer 106 588–593
JP Struewing P Hartge S Wacholder et al. (1997) ArticleTitleThe risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews N Engl J Med 336 1401–1408 Occurrence Handle10.1056/NEJM199705153362001 Occurrence Handle1:STN:280:ByiB2svgt1w%3D Occurrence Handle9145676
SA Gayther P Harrington P Russell et al. (1997) ArticleTitleFrequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia Am J Hum Genet 60 1239–1242 Occurrence Handle1:CAS:528:DyaK2sXjtlOqs7g%3D Occurrence Handle9150173
IV Tereschenko VM Basham BA Ponder et al. (2002) ArticleTitleBRCA1 and BRCA2 mutations in Russian familial breast cancer Hum Mutat 19 184 Occurrence Handle10.1002/humu.9008
SJ Ramus Z Kote-Jarai LS Friedman et al. (1997) ArticleTitleAnalysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer Am J Hum Genet 60 1242–1246 Occurrence Handle1:CAS:528:DyaK2sXjtlOqs7k%3D Occurrence Handle9150174
E Machackova L Foretova M Navratilova et al. (2000) ArticleTitleA high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast–ovarian cancer families Cas Lek Cesk 139 635–637 Occurrence Handle1:STN:280:DC%2BD3M7ks1CnsA%3D%3D Occurrence Handle11192759
E Grzybowska H Zientek A Jasinska et al. (2000) ArticleTitleHigh frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer Hum Mutat 16 482–490 Occurrence Handle10.1002/1098-1004(200012)16:6<482::AID-HUMU5>3.0.CO;2-O Occurrence Handle1:CAS:528:DC%2BD3MXhs1eksQ%3D%3D Occurrence Handle11102977
O Oszurek B Gorski J Gronwald et al. (2001) ArticleTitleFounder mutations in the BRCA1 gene in west Belarusian breast–ovarian cancer families Clin Genet 60 470–471 Occurrence Handle10.1034/j.1399-0004.2001.600611.x Occurrence Handle1:STN:280:DC%2BD387htlagtA%3D%3D Occurrence Handle11846741
LS Friedman EA Ostermeyer CI Szabo et al. (1994) ArticleTitleConfirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families Nat Genet 8 399–404 Occurrence Handle10.1038/ng1294-399 Occurrence Handle1:CAS:528:DyaK2MXitl2hsb0%3D Occurrence Handle7894493
Breast Cancer Information Core: http://www.nhgri.nih.gov/ Intramural_research/Lab_transfer/Bic/.
Uitenbroek DG. 1997. Binomial. SISA. http://home.clara.net/sisa/binomial.htm. Accessed 1 January 2002.
A. Meindl (2002) ArticleTitleGerman consortium for hereditary breast and ovarian cancer: Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population Int J Cancer 97 472–480
AN Loginova NI Pospekhova LN Lyubchenko et al. (2003) ArticleTitleSpectrum of mutations in BRCA1 gene in hereditary forms of breast and ovarian cancer in Russian families Bull Exp Biol Med 136 276–278 Occurrence Handle10.1023/B:BEBM.0000008982.21806.9b Occurrence Handle1:CAS:528:DC%2BD3sXpvVGnsLY%3D Occurrence Handle14666193
J Backe S Hofferbert B Skawran et al. (1999) ArticleTitleFrequency of BRCA1 mutation 5382insC in German breast cancer patients Gyn Oncol 72 402–406 Occurrence Handle10.1006/gyno.1998.5270 Occurrence Handle1:CAS:528:DyaK1MXhsVegsbc%3D
SA Gayther W Warren S Mazoyer et al. (1995) ArticleTitleGermline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype phenotype correlation Nat Genet 11 IssueID4 428–433 Occurrence Handle10.1038/ng1295-428 Occurrence Handle1:CAS:528:DyaK2MXpvVCksLc%3D Occurrence Handle7493024
HA Risch JR McLaughlin DE Cole et al. (2001) ArticleTitlePrevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer Am J Hum Genet 68 700–710 Occurrence Handle10.1086/318787 Occurrence Handle1:CAS:528:DC%2BD3MXit1aksr8%3D Occurrence Handle11179017
D Thompson D. Easton (2002) ArticleTitleBreast cancer linkage consortium: variation in BRCA1 cancer risks by mutation position Cancer Epidemiol Biomarkers Prev 11 329–336 Occurrence Handle1:CAS:528:DC%2BD38XjtlCmtrw%3D Occurrence Handle11927492
P Hohenstein R. Fodde (2003) ArticleTitleOf mice and (wo)men: genotype–phenotype correlations in BRCA1 Hum Mol Genet 12 R271–277 Occurrence Handle10.1093/hmg/ddg258 Occurrence Handle1:CAS:528:DC%2BD3sXotlWisr8%3D Occurrence Handle12915453
A Jasinska WJ. Krzyzosiak (2001) ArticleTitlePrevalence of BRCA1 founder mutations in western Poland Hum Mutat 17 75 Occurrence Handle10.1002/1098-1004(2001)17:1<75::AID-HUMU15>3.0.CO;2-9 Occurrence Handle1:STN:280:DC%2BD3M7isV2iug%3D%3D
M VanDer Looij C Szabo I Besznyak et al. (2000) ArticleTitlePrevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary Int J Cancer 86 737–740 Occurrence Handle10.1002/(SICI)1097-0215(20000601)86:5<737::AID-IJC21>3.0.CO;2-1 Occurrence Handle1:CAS:528:DC%2BD3cXjslSlsbo%3D Occurrence Handle10797299
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tikhomirova, L., Sinicka, O., Smite, D. et al. High prevalence of two BRCA1 mutations, 4154delA and 5382insC, in Latvia. Familial Cancer 4, 77–84 (2005). https://doi.org/10.1007/s10689-004-2758-3
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10689-004-2758-3